The BioRegion is the healthcare and life sciences ecosystem in Catalonia, meaning the group of companies, research groups and bodies, hospitals, universities, administrations, researchers and entrepreneurs, innovation and knowledge-transfer support structures working in Catalonia in this strategic sector.
With a population of more than 7.5 millions and territory comparable to that of European countries like Belgium or the Netherlands, Catalonia has the most dynamic life sciences ecosystem in Spain and one of the most active in Europe. Biocat is the body responsible for dynamizing and promoting the BioRegion of Catalonia.
Startups in the BioRegion of Catalonia, the Catalan healthcare and life sciences sector, attracted a joint total of €106.1 million in funding in 2018, up 1.9% from the previous year. For the third time in a row, Financial Times has selected Catalonia as the best Southern European region for investment in 2020-2021.
Catalonia is among the top 10 countries in Europe in terms of participation in clinical trials and among the top 20 in the world; looking at oncology alone, it is in the European Top 5 and the global Top 10. Quality, safety, fast recruitment of patients, KOLs and competitive costs make the BioRegion of Catalonia a location of choice for clinical trials.
One out of six scientific biomedicine publications signed by researchers from the BioRegion of Catalonia (specifically 16.5%) are among the 1% of the most cited publications in the world: triple than would correspond to their volume of production. In the last 20 years, the number of biomedicine publications has almost quadrupled in Catalonia and it represents 1.2% of the all world, 3.51% of Europe (28 of the EU), and 34.1% of Spain.